Why on earth is Craig Biggio above steroid suspicion?

71 Comments

Here we have Bill Madden’s latest gem of a column, which contains enough strawmen to fill up Citi Field. In it, he promotes Jack Morris and Craig Biggio for the Hall of Fame, and while he doesn’t unequivocally state that they are the only two players he is voting for, the column certainly suggests it.

I’ve tackled Morris before and will again tomorrow, but let’s concentrate on Biggio for a moment. Biggio is being promoted by Madden and others as this year’s clean candidate, whereas his longtime Astros teammate, Jeff Bagwell, has had his candidacy tainted by steroids.

What I don’t get is why one if not the other?

The case against Bagwell is that he showed little power as a youngster, befriended noted steroids user Ken Caminti, got a lot stronger in the majors and then turned into one of the game’s best players.

And that differs from Biggio how? Biggio hit four homers in 555 at-bats at age 24, four homers in 546 at-bats at age 25 and six homers in 613 at-bats at age 26 before turning in the first of seven 20-homer campaigns at age 27.  His career high of 26 homers came at age 39.

Furthermore, Bagwell and Biggio were good friends who spent 15 years as teammates. I have my doubts that the training methods of one were a secret to the other. If Bagwell was on something, one would think there’s a more than slight chance that Biggio was on it, too.

So why does Biggio get trumped up as clean? Because he was a middle infielder? Because he hit 20 homers per year rather than 40? I’ll give you that Biggio wasn’t quite as stacked as Bagwell in his prime, but the guy had some muscles.

Personally, I’m very much in favor of putting Biggio into the Hall, just as I’m in favor of Bagwell’s candidacy. Part of Biggio’s power spike can be attributed to him leaving the Astrodome for Enron Field/Minute Maid Park. Towards the end of his career, once he realized he could no longer cover the entire plate, he made a conscious decision to become more of a pull hitter and take aim at the shallow left field porch at Enron.

Biggio was a favorite of mine, and I’d like to think he spent his entire career steroid-free. My point here isn’t to label Biggio a cheater. It’s simply to say that we don’t know, and that anyone that would go to lengths to promote him as the clean candidate is either naive or stupid.

Kevin Gausman to start Opening Day for the Orioles

Patrick Smith/Getty Images
Leave a comment

The Orioles have tabbed Kevin Gausman to start on Opening Day, April 3 against the Blue Jays at Camden Yards, MASN’s Roch Kubatko reports. Chris Tillman started the previous three Opening Days for the O’s. This will be Gausman’s first Opening Day nod.

Gausman, 26, finished the 2016 season with a 3.61 ERA and a 174/47 K/BB ratio in 179 2/3 innings. The Orioles selected him in the first round (fourth overall) of the 2012 draft and moved him through their minor league system quickly. Gausman debuted in the majors in May 2013.

2017 Preview: Detroit Tigers

Getty Images
8 Comments

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2017 season. Next up: The Detroit Tigers.

I feel like every year, for the past several years, our Tigers preview has been some variation of “do the Tigers still have a run left in them with the Cabrera-Verlander core?”

If you’re tired of reading that one I have some bad news for you: it’s the same dang story this year as it has been every year. A great pitcher and a great hitter, a very solid supporting cast, a handful of holes that could be critical weaknesses and enough to make them look strong enough to contend but not enough to contend strongly, if that makes any sense.

Let’s start with the pitching. Justin Verlander returned to Cy Young-caliber form in 2016, thanks mostly to health and a big, big leap in his strikeout rate, suggesting that it was health and not an overall decline which harmed him in 2014 and 2015. He’ll lead the way again, followed by Rookie of the Year Michael Fulmer, who was a wonderful surprise last season. The back end of the rotation is problematic, however, with Jordan Zimmermann and Anibal Sanchez stinking up the joint for most of last year and young Daniel Norris suffering through injuries. For the Tigers to contend, they’ll need at least one of those veterans to return to their old form — or someone like Matt Boyd or Mike Pelfrey to, well, not be Matt Boyd and Mike Pelfrey– and for Norris to be healthy.

Fine, let’s say Verlander and Fulmer repeat their 2016 success and say that Norris is a strong, healthy and effective number three. Who then does Brad Ausmus turn the ball over to in the late innings? If you think the overall take on the Tigers is rehashed from year to year, well, the same goes for the pen. It, as always, is a liability in Detroit. And it’s not going to be terribly different than it was last year. Francisco Rodriguez will close. A couple of Wilsons in Alex and Justin. Shane Greene. Maybe one of the veteran starters who doesn’t make the rotation. The always interesting Bruce Rondon. It’s not terrible but it’s not the strongest bunch in the world and it’s being handled by a guy in Ausmus who has yet to show that he can get the most out of a less-than-steller relief corps. You can Google the phrase “Tigers bullpen woes” and find results from every season for most of the past decade. You’ll probably be able to do it again this year.

The offense, of course, is fantastic, at least at the top end. Miguel Cabrera is still an MVP-caliber player and even when his decline begins he’ll be better than almost any hitter in the game. Ian Kinsler is still low-key excellent. Nick Castellanos took a big leap forward last year. J.D. Martinez is going to miss the first month or so of the season with a sprained ligament in his foot, but he’s in his walk year and will likely be fine once he returns. Justin Upton has always been super uneven and has always failed to meet the insane expectations he set early in his career, but as he showed late last season, he’s capable of carrying a team for a stretch. I’ve been saying it for a pushing a decade, but one of these years he’s going to put it all together.

The big question is going to be the bottom third of the lineup where catcher James McCann, shortstop Jose Iglesias and center fielder Tyler Collins all look to be offensive liabilities at the moment. A bigger than usual year from any of them could help matters greatly.

Of course all of this — the strong lineup with critical holes, the rotation that starts well but has question marks and the spotty bullpen — has been the Tigers story for years. It’s a story that could end happily with 85-90 wins, a playoff spot and a bunch of seasoned veterans getting hot at the right time and riding it to glory. It could just as easily get sprinkled with a slow start or a few injuries and result in a 75-80 win season like they had back in 2015.

In the past, that would lead to yet another “wait until next year.” This year, however, you get the strong sense that there is no next year if this year is disappointing. There was talk that the Tigers could sell off veteran parts this past winter, but they didn’t. Then longtime owner Mike Ilitch, who was seen as a man who pushed to win now despite the costs, passed away in February. It’s not hard to imagine his son giving different instructions to GM Al Avila if the Tigers don’t get off to a fast start this year. It’s not hard to imagine the great unwinding of the core that has kept this Tigers team in contention for so long if 2017 is a disappointment.

I’m still optimistic, though. The Indians are the class of the division but the Royals are likely taking a step back and the Twins and White Sox are not yet a threat. I won’t predict October glory for them, but I think, barring major injuries to key players, the Tigers will be playing meaningful baseball in September.

Prediction: Second place, American League Central